Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.02 -0.02 (-1.92%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Total Debt (2022)

Updated

Cadrenal Therapeutics (CVKD) reported Total Debt of $43,728 for Q4 2022.

Analysis

Cadrenal Therapeutics (CVKD) Total Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Cadrenal Therapeutics 2.95 Mn -9.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 293,728.00
API Access

Cadrenal Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=CVKD&period=max&api_key=YOUR_API_KEY